Sandler Alan B. 4
4 · Mirati Therapeutics, Inc. · Filed Nov 8, 2022
Insider Transaction Report
Form 4
Sandler Alan B.
Chief Medical Officer
Transactions
- Award
Common Stock
2022-11-07+40,000→ 40,000 total - Award
Stock Option (Right to buy)
2022-11-07+65,000→ 65,000 totalExercise: $0.00Exp: 2032-11-06→ Common Stock (65,000 underlying)
Footnotes (2)
- [F1]This represents a Restricted Stock Unit grant with a vesting period of 4 years that vests 25% annually from grant date and subject to the reporting persons continuously service to the issuer.
- [F2]25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.